Mobile

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

Mise à jour : Il y a 4 ans
Référence : NCT01340027

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The purpose of this study is to examine how well two medicines in combination (solifenacin succinate and mirabegron) work in the treatment of bladder problems over a 12-week period.

Critère d'inclusion

  • Urinary Bladder, Overactive,Urinary Bladder Diseases,Urologic Diseases,Urological Manifestations,Signs and Symptoms

Liens